Sinovac Biotech has sold more than 300 million doses of the vaccine, CoronaVac, to the developing world.
- Test conducted in the state of São Paulo
- said the inoculation had an efficacy rate of 78 percent
- The vaccine prevented all participants from developing serious and mild complications from the virus, officials said, calling it a highly effective preventive tool.
Link here to the NYT for more.
78% does not sound that impressive?
